ESAB Corporation Announces First Quarter 2025 Results

Business Wire

02-05-2025

NORTH BETHESDA, Md.--(BUSINESS WIRE)--ESAB Corporation ('ESAB' or the 'Company') (NYSE: ESAB), a focused premier industrial compounder, today announced financial results for the first quarter of 2025.
ESAB reported first quarter sales of $678 million, a decrease of 2% on a reported basis or flat on a core organic growth basis before acquisitions and currency translation, as compared to the prior year. ESAB also reported first quarter net income from continuing operations attributable to ESAB of $70 million or $1.14 diluted earnings per share and core adjusted net income of $77 million or $1.25 diluted earnings per share. Core adjusted EBITDA of $128 million rose 4% and margin expanded 100 basis points to 19.8%, both as compared to the prior year quarter.
'ESAB delivered strong first-quarter results, with our team's continued focus on EBX driving positive growth and record margin performance amid challenging market conditions,' stated Shyam P. Kambeyanda, President and CEO of ESAB. 'We are building ESAB into a premier industrial compounder with a comparative advantage that delivers sustained, long-term value for our shareholders. Over the past eight years, we have centered our strategy on leveraging our global scale while maintaining local agility to serve customers. We continue to make growth investments, pursue strategic bolt-on and tuck-in acquisitions to advance our priorities, and deploy EBX to enhance margins. This foundation and global footprint have enabled us to outperform during the pandemic and the subsequent inflationary period—and positions us well to navigate today's tariff uncertainties with confidence.'
Full Year 2025 Outlook
ESAB raises its full year 2025 outlook for total core sales growth of (1.0)% to 1.5%, core organic sales growth of 0.0% to 2.0%, M&A of 2.0% to 2.5% and FX of ~(3.0)% from its prior outlook of total core sales growth of (2.0)% to 0.0%, core organic sales growth of 0.0% to 2.0%, M&A of ~1.5% and FX of ~(3.5)%. ESAB's core adjusted EBITDA outlook increases to $520 to $530 million versus prior guidance of $515 to $530 million, and core adjusted EPS remains $5.10 to $5.25.
About ESAB Corporation
Founded in 1904, ESAB Corporation is a focused industrial compounder. The Company's rich history of innovative products, workflow solutions and its business system ESAB Business Excellence ('EBX'), enables the Company's purpose of Shaping the world we imagine TM. ESAB Corporation is based in North Bethesda, Maryland and employs approximately 9,300 associates and serves customers in approximately 150 countries. To learn more, visit www.ESABcorporation.com.
About Bavaria
On April 30, 2025, ESAB successfully completed the acquisition of Bavaria Schweisstechnik GmbH, a European enterprise. This strategic move enhances our consumables portfolio and aligns ESAB's proprietary consumables offering towards faster-growing end markets.
Conference Call and Webcast
The Company will hold a conference call to discuss its first quarter 2025 results beginning at 8:00 a.m. Eastern on Thursday, May 1, 2025, which will be open to the public by calling [phone] (U.S. callers) and [phone] (International callers) and referencing the conference ID number 4669992 and through webcast via ESAB's website www.ESABcorporation.com under the 'Investors' section. Access to a supplemental slide presentation can also be found on ESAB's website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call. The Company's quarterly report on Form 10-Q for the fiscal quarter ended April 4, 2025, filed May 1, 2025, is also available on ESAB's website under the 'Investors' section.
Non-GAAP Financial Measures and Other Adjustments
ESAB has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the United States ('non-GAAP'). ESAB presents some of these non-GAAP financial measures including and excluding Russia due to economic and political volatility caused by the war in Ukraine, which results in enhanced investor interest in this information. Core non-GAAP financial measures exclude Russia for the three months ended April 4, 2025 and March 29, 2024. These non-GAAP financial measures may include one or more of the following: adjusted net income from continuing operations, Core adjusted net income from continuing operations, adjusted EBITDA (earnings before interest, taxes, Pension settlement loss, Restructuring and other related charges, acquisition-amortization and other related charges and depreciation and other amortization), Core adjusted EBITDA, organic sales, Core organic sales, adjusted free cash flow and ratios based on the foregoing measures. ESAB also provides adjusted EBITDA and adjusted EBITDA margin on a segment basis, as well as Core adjusted EBITDA and Core adjusted EBITDA margin on a segment basis.
Adjusted net income from continuing operations represents Net income from continuing operations attributable to ESAB Corporation, excluding Restructuring and other related charges, acquisition-amortization and other related charges and Pension settlement loss. Adjusted net income, includes the tax effect of non-GAAP adjusting items at applicable tax rates and excludes the impact of discrete tax charges or gains in each period. ESAB also presents adjusted net income margin from continuing operations, which is subject to the same adjustments as adjusted net income from continuing operations. Adjusted net income per diluted share from continuing operations is a calculation of adjusted net income from continuing operations over the weighted-average diluted shares outstanding. ESAB also presents Core adjusted net income from continuing operations and Core adjusted net income per share - diluted from continuing operations, which are subject to the same adjustments as Adjusted net income from continuing operations and Adjusted net income per diluted share from continuing operations, further removing the impact of Russia for the three months ended April 4, 2025 and March 29, 2024.
Adjusted EBITDA excludes from Net income from continuing operations the effect of Income tax expense, Interest expense and other, net, Restructuring and other related charges, acquisition-amortization and other related charges, Pension settlement loss and depreciation and other amortization. ESAB presents adjusted EBITDA margin, which are subject to the same adjustments as adjusted EBITDA. Further, ESAB presents these non-GAAP performance measures on a segment basis, which excludes the impact of Restructuring and other related charges, acquisition-amortization and other related charges, Pension settlement loss and depreciation and other amortization from operating income. ESAB also presents Core adjusted EBITDA and Core adjusted EBITDA margin, which are subject to the same adjustments as Adjusted EBITDA and Adjusted EBITDA margin, respectively, further removing the impact of Russia for the three months ended April 4, 2025 and March 29, 2024.
ESAB presents organic sales, which excludes the impact of acquisitions and foreign exchange rate fluctuations and presents core organic sales, which further excludes the impact of the Russia business for the three months ended April 4, 2025 and March 29, 2024.
Adjusted free cash flow represents cash flows from operating activities excluding cash outflows related to discontinued operations, less Purchases of property, plant and equipment.
These non-GAAP financial measures assist ESAB management in comparing its operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to unusual events or discrete restructuring plans and other initiatives that are fundamentally different from the ongoing productivity and core business of the Company.
ESAB management also believes that presenting these measures allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.
Forward Looking Statements
This press release includes forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning the Company's plans, goals, objectives, outlook, expectations, and intentions, and other statements that are not historical or current fact. Forward-looking statements are based on the Company's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements, including general risks and uncertainties such as market conditions, economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism, wars or conflicts, major health concerns, natural disasters or other disruptions of expected business conditions. Factors that could cause the Company's results to differ materially from current expectations include, but are not limited to, risks related to the impact of the wars in Ukraine and Middle East and the resulting escalating geopolitical tensions; impact of supply chain disruptions; the impact of creditworthiness and financial viability of customers; impact of inflationary pressures, tariffs and trade policies, foreign exchange fluctuations and commodity prices; risks related to the war in Ukraine and the conflict in the Middle East and the resulting escalating geopolitical tensions; other impacts on the Company's business and ability to execute business continuity plans; and the other factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission ('SEC') on February 20, 2025, as well as other risks discussed in the Company's filings with the SEC. In addition, these statements are based on assumptions that are subject to change. This press release speaks only as of the date hereof. The Company disclaims any duty to update the information herein.
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Dollars in millions, except per share data
(Unaudited)
Three Months Ended
April 4, 2025
March 29, 2024
Adjusted Net Income
Net income from continuing operations (GAAP)
$
72.6
$
62.9
Less: Income attributable to noncontrolling interest, net of taxes
2.5
1.6
Net income from continuing operations attributable to ESAB Corporation (GAAP)
70.1
61.3
Restructuring and other related charges – pretax (1)
4.5
1.9
Acquisition-amortization and other related charges – pretax (2)
9.6
7.7
Pension settlement loss – pretax
—
12.2
Tax effect on above items (3)
(3.5
)
(5.3
)
Adjusted net income from continuing operations (non-GAAP)
80.7
77.8
Adjusted net income from continuing operations attributable to Russia (non-GAAP) (4)
3.8
4.2
Core adjusted net income from continuing operations (non-GAAP)
$
76.9
$
73.6
Adjusted net income margin from continuing operations
11.9
%
11.3
%
Adjusted Net Income Per Share
Net income per share – diluted from continuing operations (GAAP)
$
1.14
$
1.00
Restructuring and other related charges – pretax (1)
0.07
0.03
Acquisition-amortization and other related charges – pretax (2)
0.16
0.13
Pension settlement loss – pretax
—
0.20
Tax effect on above items (3)
(0.06
)
(0.09
)
Adjusted net income per share – diluted from continuing operations (non-GAAP)
1.31
1.27
Adjusted net income per share – diluted from continuing operations attributable to Russia (non-GAAP) (4)
0.06
0.07
Core adjusted net income per share – diluted from continuing operations (non-GAAP)
$
1.25
$
1.20
Expand
__________
(1)
Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.
(2)
Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(3)
This line item reflects the aggregate tax effect of all non-tax adjustments reflected in the proceeding line items of the table. ESAB estimates the tax effect of each adjustment item by applying ESAB's overall estimated effective tax rate to the pretax amount, unless the nature of the item and/or tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment.
(4)
Represents Russia contribution for the three months ended April 4, 2025 and March 29, 2024.
Expand
ESAB CORPORATION
Dollars in millions
(Unaudited)
Three Months Ended April 4, 2025 (1)
Americas
EMEA & APAC
Total
Net income from continuing operations (GAAP)
$
72.6
Income tax expense
20.5
Interest expense and other, net
16.8
Operating income (GAAP)
$
43.2
$
66.6
$
109.8
Adjusted to add
Restructuring and other related charges (2)
1.7
2.8
4.5
Acquisition-amortization and other related charges (3)
5.6
4.0
9.6
Depreciation and other amortization
3.9
6.0
10.0
Adjusted EBITDA (non-GAAP)
54.5
79.4
133.9
Adjusted EBITDA attributable to Russia (non-GAAP) (4)
—
6.0
6.0
Core adjusted EBITDA (non-GAAP)
$
54.5
$
73.4
$
127.9
Adjusted EBITDA margin (non-GAAP)
19.4
%
20.0
%
19.7
%
Core adjusted EBITDA margin (non-GAAP) (5)
19.4
%
20.0
%
19.8
%
Expand
__________
(1)
Numbers may not sum due to rounding.
(2)
Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.
(3)
Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(4)
Numbers calculated following the same definition as Adjusted EBITDA for total Company.
(5)
Net sales were $31.3 million relating to Russia for the three months ended April 4, 2025.
Expand
Three Months Ended March 29, 2024 (1)
Net income from continuing operations (GAAP)
$
62.9
Income tax expense
18.5
Interest expense and other, net
17.1
Pension settlement loss
12.2
Operating income (GAAP)
$
46.0
$
64.7
$
110.7
Adjusted to add
Restructuring and other related charges (2)
0.2
1.7
1.9
Acquisition-amortization and other related charges (3)
4.4
3.3
7.7
Depreciation and other amortization
3.5
5.3
8.8
Adjusted EBITDA (non-GAAP)
54.1
75.0
129.1
Adjusted EBITDA attributable to Russia (non-GAAP) (4)
—
5.9
5.9
Core adjusted EBITDA (non-GAAP)
$
54.1
$
69.1
$
123.2
Adjusted EBITDA margin (non-GAAP)
18.3
%
19.1
%
18.7
%
Core adjusted EBITDA margin (non-GAAP) (5)
18.3
%
19.2
%
18.8
%
Expand
(1)
Numbers may not sum due to rounding.
(2)
Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.
(3)
Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(4)
Numbers calculated following the same definition as Adjusted EBITDA for total Company.
(5)
Net sales were $33.6 million relating to Russia for the three months ended March 29, 2024.
Expand
Sales (1)
Americas
EMEA & APAC
Total ESAB
$
Change %
$
Change %
$
Change %
For the three months ended March 29, 2024
$
296.0
$
393.7
$
689.7
Components of Change:
Existing businesses (organic sales) (2)
(7.0
)
(2.4
)%
5.9
1.5
%
(1.1
)
(0.2
)%
Acquisitions (3)
9.6
3.2
%
5.2
1.3
%
14.8
2.1
%
Foreign Currency translation (4)
(17.9
)
(6.1
)%
(7.4
)
(1.9
)%
(25.3
)
(3.7
)%
Total sales (decline) growth
(15.4
)
(5.2
)%
3.8
1.0
%
(11.6
)
(1.7
)%
For the three months ended April 4, 2025
$
280.7
$
397.5
$
678.1
Expand
(1)
Numbers may not sum due to rounding.
(2)
Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(3)
Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(4)
Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.
Expand
Core Sales (1)(5)
Americas
EMEA & APAC
ESAB
$
Change %
$
Change %
$
Change %
For the three months ended March 29, 2024
$
296.0
$
360.1
$
656.1
Components of Change:
Existing businesses (core organic sales) (2)
(7.0
)
(2.4
)%
8.4
2.3
%
1.3
0.2
%
Acquisitions (3)
9.6
3.2
%
5.2
1.4
%
14.8
2.3
%
Foreign Currency translation (4)
(17.9
)
(6.1
)%
(7.4
)
(2.1
)%
(25.4
)
(3.9
)%
Total core sales (decline) growth
(15.4
)
(5.2
)%
6.1
1.7
%
(9.2
)
(1.4
)%
For the three months ended April 4, 2025
$
280.7
$
366.2
$
646.9
Expand
(1)
Numbers may not sum due to rounding.
(2)
Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(3)
Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(4)
Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.
(5)
Represents sales excluding Russia for the three months ended April 4, 2025 and March 29, 2024.
Expand
ESAB CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Adjusted Free Cash Flow
Dollars in millions
(Unaudited)
Three Months Ended
April 4, 2025
March 29, 2024
Net cash provided by operating activities (GAAP)
$
35.4
$
44.5
Purchases of property, plant and equipment (GAAP)
(7.3
)
(7.4
)
Payments related to discontinued operations
2.3
3.7
Adjusted free cash flow (non-GAAP)
$
30.4
$
40.8
Expand
ESAB CORPORATION
2025 Outlook
Dollars in millions, except per share amounts
(Unaudited)
ESAB 2025 Outlook
Previous Guidance
New Guidance
2024 Core net sales
$
2,591.2
$
2,591.2
Organic growth
0.0%-2.0%
0.0%-2.0%
Acquisitions
~1.5%
2.0%-2.5%
Currency
~(3.5)%
~(3.0)%
2025 Core net sales growth range
(2.0)%-0.0%
(1.0)%-1.5%
2024 Core adjusted EBITDA
$
510.7
$
510.7
2025 Core adjusted EBITDA range
$515 - $530
$520 - $530
2024 Core adjusted EPS
$
5.06
$
5.06
2025 Core adjusted EPS range
$5.10 - $5.25
$5.10 - $5.25
Expand
ESAB CORPORATION
CONSOLIDATED AND CONDENSED BALANCE SHEETS
Dollars in thousands, except share and per share amounts
(Unaudited)
December 31, 2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
$
291,348
$
249,358
Trade receivables, less allowance for credit losses of $24,446 and $23,850
414,796
370,321
Inventories, net
450,705
403,711
Prepaid expenses
56,941
55,665
Other current assets
72,241
69,327
Total current assets
1,286,031
1,148,382
Property, plant and equipment, net
307,487
298,347
Goodwill
1,684,829
1,651,993
Intangible assets, net
502,895
487,993
Lease assets - right of use
86,320
89,859
Other assets
349,980
357,401
Total assets
$
4,217,542
$
4,033,975
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Current portion of debt
$
17,759
$
15,000
Accounts payable
349,716
318,493
Accrued liabilities
304,525
298,558
Total current liabilities
672,000
632,051
Long-term debt
1,056,296
1,060,739
Other liabilities
538,854
532,936
Total liabilities
2,267,150
2,225,726
Equity:
Common stock - $0.001 par value - Authorized 600,000,000, 60,622,736 and 60,517,574 shares outstanding as of April 4, 2025 and December 31, 2024, respectively
61
61
Additional paid-in capital
1,901,849
1,901,337
Retained earnings
659,675
597,180
Accumulated other comprehensive loss
(651,857
)
(729,574
)
Total ESAB Corporation equity
1,909,728
1,769,004
Noncontrolling interest
40,664
39,245
Total equity
1,950,392
1,808,249
Total liabilities and equity
$
4,217,542
$
4,033,975
Expand
ESAB CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF CASH FLOWS
Dollars in thousands
(Unaudited)
Three Months Ended
April 4, 2025
March 29, 2024
Cash flows from operating activities:
Net income
$
69,832
$
61,594
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other impairment charges
17,491
16,387
(Gain) loss on sale of property, plant and equipment
(5,665
)
44
Stock-based compensation expense
5,361
4,133
Deferred income tax
(2,774
)
(638
)
Non-cash interest expense
628
1,062
Pension settlement loss
—
12,155
Changes in operating assets and liabilities:
Trade receivables, net
(32,026
)
(48,946
)
Inventories, net
(35,393
)
(16,078
)
Accounts payable
21,405
36,196
Other operating assets and liabilities
(3,449
)
(21,442
)
Net cash provided by operating activities
35,410
44,467
Cash flows from investing activities:
Purchases of property, plant and equipment
(7,294
)
(7,414
)
Proceeds from sale of property, plant and equipment
4,605
368
Acquisition, net of cash received
—
(18,067
)
Other investing
—
(1,501
)
Net cash used in investing activities
(2,689
)
(26,614
)
Cash flows from financing activities:
Proceeds from borrowings on revolving credit facilities and other
—
115,000
Repayments of borrowings on Term Loans
(2,500
)
(6,250
)
Repayments of borrowings on revolving credit facilities and other
—
(135,005
)
Payment of dividends
(4,861
)
(3,635
)
Distributions to noncontrolling interest holders
(1,168
)
—
Other financing
(4,590
)
(4,030
)
Net cash used in financing activities
(13,119
)
(33,920
)
Effect of foreign exchange rates on Cash and cash equivalents
22,388
(9,441
)
Increase (decrease) in Cash and cash equivalents
41,990
(25,508
)
Cash and cash equivalents, beginning of period
249,358
102,003
Cash and cash equivalents, end of period
$
291,348
$
76,495
Expand